瞳孔大小作为视觉结果的预测因子,使用增强的单焦眼内眼镜
Seung Hyeun Lee1, Yeoun Sook Chun2, Kyoung Woo Kim2
1Department of Ophthalmology, Institute of Clinical Medicine, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong-si, Korea.
Clinical & experimental optometry
|February 17, 2026
概括
瞳孔大小显著影响视力,增强的单焦眼内眼透镜. 通过Anterion测量较大的瞳孔 (≥4.0毫米),与接受Tecnis Eyhance ICB00的患者更好的未经校正的距离视敏度 (UCDVA) 相相关.
科学领域:
- 眼科医生 眼科 眼科
- 光学工程是指光学工程.
- 医疗成像医学成像
背景情况:
- 增强的单焦眼内眼镜 (IOL) 旨在改善中间视力,而不会牺牲距离敏度.
- 这些内腔眼镜的患者结果可能会有所不同,瞳孔大小被确定为潜在的影响因素.
- 前段扫描源光学连贯性断层扫描 (AS SS-OCT) 为患者选择提供了精确的瞳孔大小评估.
研究的目的:
- 研究植入了Tecnis Eyhance ICB00增强单焦内科眼镜的患者的瞳孔大小和视觉结果之间的关系.
- 为了比较从两个不同的AS SS-OCT设备 (Anterion和IOLMaster 700) 获得的瞳孔尺寸测量.
- 分析瞳孔大小对未经纠正的远视敏度 (UCDVA) 的影响.
主要方法:
- 追溯分析了45名接受Tecnis Eyhance ICB00 IOL的患者的64只眼睛.
- 使用Anterion®和IOLMaster 700 AS SS-OCT设备进行术前和术后的瞳孔尺寸测量.
- 基于3.5毫米和4.0毫米的瞳孔尺寸值的UCDVA分析;对IOL厚度配置的比较.
主要成果:
- 术后瞳孔大小≥4.0mm (Anterion) 与较好的UCDVA (LogMAR 0.08) 与<4.0mm (LogMAR 0.19) 相比显著相关.
- 通过Anterion测量的手术前瞳孔大小观察到类似的趋势; IOLMaster 700测量与视觉结果没有相关性.
- 安特里昂始终测量出比IOLMaster 700更大的瞳孔尺寸 (平均差异:0.56毫米);艾汉斯IOL显示中心曲率比ZCB00.00更.
结论:
- 术前和术后的瞳孔大小≥4.0毫米,通过Anterion测量,与增强的单焦IOLs改善的UCDVA有关.
- 需要进一步的研究来确定观察到的效应是由于透镜设计或生理因素,如衍射.
- 在AS SS-OCT设备之间的瞳孔尺寸测量的差异需要标准化努力.
相关概念视频
01:16Focusing of Light in the Eye
6.4K
Light rays enter the eye through the cornea, a transparent dome-shaped tissue that is the eye's outermost layer. The cornea bends or refracts, light rays traveling to the pupil. The shape of the cornea determines how much of the light is bent and whether the image will be focused correctly on the retina at the back of the eye. Once the light has passed through both refraction layers, it converges into a single focal point onto a small area. This is where photoreceptors start transforming...
6.4K
01:27Open Angle Glaucoma: Treatment
1.0K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.0K
01:28Angle Closure Glaucoma: Treatment
1.4K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.4K
01:25Glaucoma: Overview
1.4K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.4K